Trial · NCT03096431
Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT
NCT03096431, Not applicable, Terminated, Virginia Commonwealth University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT. Trials, record NCT03096431. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03096431
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT
- NCT number
- NCT03096431
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 2 participants, actual
- Lead sponsor
- Virginia Commonwealth University
- Conditions
- Metastatic Brain Tumor, Cerebral Metastases
- Interventions
- Physical Activity, Cognitive rehabilitation
- First posted
- 2017-03-30
- Last updated
- 2018-07-13
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment percentage of eligible subjects. | 18.5 months | Recruitment: success defined as enrollment rate of 19% of eligible subjects. |
| Primary | Retention percentage of participants at end-of-study. | 18.5 months | Retention: success defined as retention rate above 56% at end-of-study. |
| Primary | Non-attendance rates of participants. instructions. | 18.5 months | Participant missed or cancelled therapy sessions less than 15% of time. |
| Primary | Lengths of sessions completed. | 18.5 months | Participant completed full scheduled minutes per session ≥ 80% of time. |
| Primary | Percentage of completion of Physical Activity intervention tasks. | 18.5 months | Participant completed ≥ 80% of PA interventions (required \< 20% rest period during or between tasks). |
| Primary | Percentage of Cognitive Therapy intervention tasks. | 18.5 months | Participant completed ≥ 80% of CR interventions (required \< 20% rest period during or between tasks). |
| Secondary | Change in cognitive abilities. | 18.5 months | Composite score post-CR intervention, minus the composite score at baseline. Scores of zero indicates maintained cognition. Positive scores indicate improved cognition. Negative scores indicate declined cognition. Composite scores derived from the following four standardized tests: * The Stroop Color Word Test (SCWT) is a 3-part measure that tests the executive function area of attention. * The Trail Making Test (TMT) is a 2-part measure that tests the executive function area of complex attention. * The Rey Auditory Verbal Learning Test (AVLT) is a 6-part measure that tests the executive function area of memory. * The Clock Drawing Test (CDT) is a single measure that tests the executive function area of visuospatial relationships and praxis. |
| Secondary | Change in physical abilities. | 18.5 months | Composite scores post intervention minus scores at baseline. Scores of zero indicate maintained physical abilities. Positive scores indicate improved physical abilities. Negative scores indicate declined physical abilities. Composite scores derived from the following two standardized tests: * The Timed Up and Go (TUG) is a single measure that tests mobility, balance, and walking ability. * The 30-second Chair Stand Test (30sCST) is a single measure that tests functional lower body strength. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Clock Drawing Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03096431
GET https://conductscience.org/api/trials/v1/NCT03096431/registered